Objective Our objective was to formulate a clinical practice guideline for the management of
the pregnant woman with diabetes. Participants The Task Force was composed of a chair, …

… Ian Blumer: Consultant to or advisory board with to Animas, Bayer, BD Diabetes, BMS/AZ,
Elli Lilly, Janssen, Medtronic, Merck, Novo Nordisk, Roche, Sanofi. William Polonsky: …

OBJECTIVE To compare the effectiveness of two interventions to reduce diabetes distress (DD)
and improve glycemic control among adults with type 1 diabetes (T1D). RESEARCH …

… and final review, Lisa Stryker designed and undertook the data analyses, and Susan Guzman,
Ian Blumer and Umesh Masharani added sections to the text and completed final editing. …

Timing and frequency of SMBG should be determined individually based on the type of
diabetes, the treatment prescribed, the need for information about blood glucose (BG) levels and …

Objective. To determine whether breastfeeding reduced the risk of childhood obesity in the
infants of a multi-ethnic cohort of women with pregestational diabetes. Methods. In this …

… Ian R. Blumer … Blumer, MD …

Hypoglycemia in people with insulin-treated type 2 diabetes can be a limiting factor for
management and a barrier to optimizing glycemic control. Even mild episodes of hypoglycemia …

Insulin detemir is a new long-acting insulin analog. Though generally well tolerated, injection
site reactions have been reported in 2% of insulin detemir users (1). Most commonly, these …

Many individuals with type 2 diabetes (T2D) will eventually require insulin therapy to help
achieve and maintain adequate glycemic control. However, the use of insulin can be …